85620-84-4

Basic information

• Product Name: (S)-3,6-DIHYDRO-2H-PYRAN-3-OL
• Synonyms: (S)-3,6-DIHYDRO-2H-PYRAN-3-OL
• CAS NO: 85620-84-4
• Molecular Formula: C₅H₈O₂
• Molecular Weight: 100.11582
• Mol File: 85620-84-4.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 196.2°C at 760 mmHg
• Flash Point: 92.1°C
• Appearance: /
• Density: 1.14g/cm³
• Vapor Pressure: 0.104mmHg at 25°C
• Refractive Index: 1.5
• CAS DataBase Reference: (S)-3,6-DIHYDRO-2H-PYRAN-3-OL(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3,6-DIHYDRO-2H-PYRAN-3-OL(85620-84-4)
• EPA Substance Registry System: (S)-3,6-DIHYDRO-2H-PYRAN-3-OL(85620-84-4)

Safety Data

• Hazardous Substances Data: 85620-84-4(Hazardous Substances Data)

Usage

General Description

(S)-3,6-DIHYDRO-2H-PYRAN-3-OL, also known as (S)-linalool, is a naturally occurring compound found in many essential oils, particularly in lavender and coriander. It is widely used in the fragrance and flavoring industry due to its pleasant floral scent and sweet taste. In addition to its aromatic properties, (S)-3,6-DIHYDRO-2H-PYRAN-3-OL also possesses anti-inflammatory, anxiolytic, and sedative effects, making it a popular ingredient in aromatherapy and traditional medicine. Furthermore, it has shown potential as an insecticide, particularly against mosquitoes and fruit flies, and has been studied for its potential anti-cancer properties. Overall, (S)-3,6-DIHYDRO-2H-PYRAN-3-OL is a versatile compound with a wide range of commercial and medicinal applications.

InChI:InChI=1/C5H8O2/c6-5-2-1-3-7-4-5/h1-2,5-6H,3-4H2/t5-/m0/s1

Upstream product

• 3152-43-0 3,4-di-O-acetyl-D-arabinal 
• 3152-43-0 3,4-di-O-acetyl-D-xylal 
• 50-69-1 D-Arabinose 
• 528869-25-2 (3S,4R,5R)-2-Bromo-tetrahydro-pyran-3,4,5-triol 
• 3068-29-9 2,3,4-tri-O-acetyl-β-D-arabinosyl bromide 
• 62445-02-7 2,3,4-tri-O-acetyl-1,5-anhydro-D-arabinitol 
• 32742-34-0 1,5-Anhydro-D-arabinitol 
• 85620-83-3 (3aR,7R,7aS)-2-Ethoxy-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-ol 

Downstream Products

• 87614-58-2 (3S,4S)-3-(2-Hydroxy-ethyl)-3,4-dihydro-2H-pyran-4-ol 
• 87614-59-3 (3S,4S)-3-[2-(tert-Butyl-diphenyl-silanyloxy)-ethyl]-3,4-dihydro-2H-pyran-4-ol 
• 75452-45-8 C₂₅H₄₀O₆ 
• 87614-60-6 2-{(2S,5R)-5-[2-(tert-Butyl-diphenyl-silanyloxy)-ethyl]-5,6-dihydro-2H-pyran-2-yl}-N,N-dimethyl-acetamide 
• 87641-25-6 C₃₆H₅₀O₆Si 
• 87614-61-7 C₄₀H₄₄O₇Si 
• 87678-98-6 1-{(2S,5R)-5-[2-(tert-Butyl-diphenyl-silanyloxy)-ethyl]-5,6-dihydro-2H-pyran-2-yl}-propan-2-one 
• 87678-99-7 1-{(2S,3R,4R,5S)-5-[2-(tert-Butyl-diphenyl-silanyloxy)-ethyl]-3,4-dihydroxy-tetrahydro-pyran-2-yl}-propan-2-one 
• 71980-98-8 pseudomonic acid C 
• 12650-69-0 mupirocin 
• 75452-42-5 C₃₂H₄₄O₅Si 
• 1258605-14-9 1,5-anhydro-4-O-diphenylphosphino-2,3-dideoxy-D-glycero-pent-2-enitol 
• 1609694-49-6 (S)-5-bromo-2-(3,6-dihydro-2H-pyran-3-yloxy)benzonitrile 
• 1609694-54-3 (S)-5-bromo-2-(3,6-dihydro-2H-pyran-3-yloxy)benzaldehyde oxime 

Relevant articles and documents

CHOLINE METABOLISM INHIBITORS

The present disclosure relates to compounds, compositions and methods for inhibiting choline metabolism, e.g., conversion of choline to trimethylamine. Disclosed herein are compounds, compositions, and methods for inhibiting choline metabolism, e.g., conversion of choline to TMA. Also disclosed herein are compounds, methods and compositions for inhibiting choline metabolism by gut microbiota resulting in reduction in the formation of trimethylamine (TMA) and trimethylamine N-oxide (TMAO).

Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitors

The development of 1,3,4,4a,5,10a-hexahydropyrano[3,4-b]chromene analogs as BACE1 inhibitors is described. Introduction of the spirocyclic pyranochromene scaffold yielded several advantages over previous generation cores, including increased potency, reduced efflux, and reduced CYP2D6 inhibition. Compound 13 (BACE1 IC50 = 110 nM) demonstrated a reduction in CSF Aβ in wild type rats after a single dose.

ENANTIOSPECIFIC TOTAL SYNTHESIS OF PSEUDOMONIC ACIDS FROM ARABINOSE

The enantiospecific synthesis of pseudomonic acids from arabinose is described.